首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   135篇
  免费   4篇
基础医学   21篇
口腔科学   2篇
临床医学   8篇
内科学   28篇
神经病学   11篇
特种医学   26篇
外科学   31篇
预防医学   4篇
药学   4篇
肿瘤学   4篇
  2022年   1篇
  2021年   5篇
  2020年   2篇
  2019年   3篇
  2018年   2篇
  2017年   3篇
  2016年   4篇
  2015年   4篇
  2014年   7篇
  2013年   14篇
  2012年   20篇
  2011年   11篇
  2010年   2篇
  2008年   4篇
  2007年   6篇
  2006年   6篇
  2005年   4篇
  2004年   3篇
  2003年   1篇
  2002年   6篇
  2001年   3篇
  1999年   1篇
  1996年   1篇
  1992年   1篇
  1991年   2篇
  1989年   2篇
  1988年   5篇
  1987年   4篇
  1986年   2篇
  1985年   2篇
  1984年   2篇
  1983年   1篇
  1979年   2篇
  1972年   1篇
  1968年   1篇
  1965年   1篇
排序方式: 共有139条查询结果,搜索用时 46 毫秒
41.
42.
43.
44.
A new improved technique of erythrocyte autotransfusion is described. Autologous blood aspirated from the operative field is centrifuged, washed and reinfused in 5-10 minutes. The systems is composed of a centrifuge and vacuum pump built into the machine. The disposable set is very easy to assemble, and cost-effective. Preliminary data of 19 patients operated as emergency cases are shown. None had postoperative bleeding. Platelet count and function did not change. Even in the cirrhotic patients there were no changes in coagulation two hours after autotransfusion. The system seems easy to use, cost-effective and particularly indicated in emergency surgery.  相似文献   
45.
46.
47.
48.
This study tested the ability of A0001 (α-tocopheryl quinone; EPI-A0001), a potent antioxidant, to improve in vitro measures, glucose metabolism, and neurological function in Friedreich ataxia. We used an in vitro study of protection from cell toxicity followed by a double-blind, randomized, placebo-controlled trial of 2 doses of A0001 in 31 adults with Friedreich ataxia. The primary clinical trial outcome was the Disposition Index, a measure of diabetic tendency, from a frequently sampled intravenous glucose tolerance test, evaluated 4 weeks into therapy. Secondary neurologic measures included the Friedreich Ataxia Rating Scale. A0001 potently inhibited cell death in Friedreich ataxia models in vitro. For the clinical trial, mean guanine-adenine-adenine repeat length was 699, and mean age was 31 years. Four weeks after treatment initiation, differences in changes in the Disposition Index between subjects treated with A0001 and placebo were not statistically significant. In contrast, a dose-dependent improvement in the Friedreich Ataxia Rating Scale score was observed. Patients on placebo improved 2.0 rating scale points, whereas patients on low-dose A0001 improved by 4.9 points (P = .04) and patients on a high dose improved by 6.1 points (P < .01). Although A0001 did not alter the Disposition Index, it caused a dose-dependent improvement in neurologic function, as measured by the Friedreich Ataxia Rating Scale. Longer studies will assess the reproducibility and persistence of neurologic benefit.  相似文献   
49.
50.
Therapeutic progress has much improved the prognosis of Hodgkin's disease; therefore long-term complications of the treatment have become a major problem. Among these, the authors focused on osteonecrosis of the femoral head, and conducted a retrospective study on 182 patients treated with inverted-Y-field radiation therapy combined to MOPP chemotherapy in 129 cases. Femoral osteonecrosis was found in 6 patients (3.3%), 5 males and 1 female; 4 of them received combined modality treatment (inverted-Y radiation therapy + MOPP), and 2 radiation therapy alone. The interval between the end of treatment and the radiological finding of femoral osteonecrosis ranged from 23 to 54 months, with a mean of 35 months. On the whole, 10 cases of osteonecrosis of the femoral head (4 bilateral, and 2 unilateral) were observed, and 4 fractures involving the anatomic neck. According to our results, neither a safety dose-limit nor an optimal schedule of combination therapy could be fixed. Besides radiological features and the problems of differential diagnosis, the authors considered the pathogenesis of femoral head osteonecrosis in the patients with Hodgkin's disease treated with radiotherapy alone or combined to chemotherapy, and suggested the existence of a personal proneness to the lesion and the role of ionizing radiations, corticosteroids and cytotoxic agents, as inducing factors. Because of the different and unexpected reaction of each patient to the treatment, osteonecrosis prevention is very difficult: however, its complication may be reduced--or even avoided--by subjecting the treated patients to periodic clinical and radiological examinations.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号